
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs1.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-manuscript.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>Selective TBK1/IKKi dual inhibitors with anti-cancer potency - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="322C300B24F3920500003392712F416E.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="nihpa" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC3947486/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947486/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="International journal of cancer. Journal international du cancer" /><meta name="citation_title" content="Selective TBK1/IKKi dual inhibitors with anti-cancer potency" /><meta name="citation_author" content="Jijia Li" /><meta name="citation_author_institution" content="Department of Stomatology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China" /><meta name="citation_author_institution" content="Department of Cancer Biology, The Scripps Research Institute, Jupiter, FL 33458, USA" /><meta name="citation_author" content="Jingjia Huang" /><meta name="citation_author_institution" content="School of Life Science, Central South University, Changsha, Hunan 410008, China" /><meta name="citation_author" content="Ji-Hak Jeong" /><meta name="citation_author_institution" content="Department of Cancer Biology, The Scripps Research Institute, Jupiter, FL 33458, USA" /><meta name="citation_author" content="Sun-Jin Park" /><meta name="citation_author_institution" content="Department of Cancer Biology, The Scripps Research Institute, Jupiter, FL 33458, USA" /><meta name="citation_author" content="Rui Wei" /><meta name="citation_author_institution" content="Department of Cancer Biology, The Scripps Research Institute, Jupiter, FL 33458, USA" /><meta name="citation_author_institution" content="Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China" /><meta name="citation_author" content="Jieying Peng" /><meta name="citation_author_institution" content="Department of Stomatology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China" /><meta name="citation_author" content="Zhiyong Luo" /><meta name="citation_author_institution" content="School of Life Science, Central South University, Changsha, Hunan 410008, China" /><meta name="citation_author" content="Yen Ting Chen" /><meta name="citation_author_institution" content="Medicinal Chemistry, Translational Research Institute, The Scripps Research Institute, Jupiter, FL 33458, USA" /><meta name="citation_author" content="Yangbo Feng" /><meta name="citation_author_institution" content="Medicinal Chemistry, Translational Research Institute, The Scripps Research Institute, Jupiter, FL 33458, USA" /><meta name="citation_author" content="Jun-Li Luo" /><meta name="citation_author_institution" content="Department of Cancer Biology, The Scripps Research Institute, Jupiter, FL 33458, USA" /><meta name="citation_publication_date" content="2014/04/04" /><meta name="citation_issue" content="8" /><meta name="citation_volume" content="134" /><meta name="citation_firstpage" content="1972" /><meta name="citation_doi" content="10.1002/ijc.28507" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC3947486/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC3947486/" /><meta name="citation_pmid" content="24150799" /><meta name="DC.Title" content="Selective TBK1/IKKi dual inhibitors with anti-cancer potency" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="NIH Public Access" /><meta name="DC.Contributor" content="Jijia Li" /><meta name="DC.Contributor" content="Jingjia Huang" /><meta name="DC.Contributor" content="Ji-Hak Jeong" /><meta name="DC.Contributor" content="Sun-Jin Park" /><meta name="DC.Contributor" content="Rui Wei" /><meta name="DC.Contributor" content="Jieying Peng" /><meta name="DC.Contributor" content="Zhiyong Luo" /><meta name="DC.Contributor" content="Yen Ting Chen" /><meta name="DC.Contributor" content="Yangbo Feng" /><meta name="DC.Contributor" content="Jun-Li Luo" /><meta name="DC.Date" content="2014 Apr 15" /><meta name="DC.Identifier" content="10.1002/ijc.28507" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Selective TBK1/IKKi dual inhibitors with anti-cancer potency" /><meta property="og:type" content="article" /><meta property="og:description" content="Increasing evidence suggests that the non-canonical IKKs play critical roles in tumor genesis and development, leading to the notion that non-canonical IKKs may be good targets for cancer therapy. Here, we demonstrate that although TBK1 is not over-expressed ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947486/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" /><meta name="ncbi_feature" content="associated_data" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3947486/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=hhs%20author%20manuscript[filter]" class="navlink">HHS Author Manuscripts</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC3947486
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC3947486/pdf/nihms531308.pdf" class="int-view">PDF (3.6M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/3947486/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/3947486/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="3947486" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3947486%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="ObJOhcBXJkyTQ3k0EdgSU1xrQ9l2FDrGR8kfwdAB8vcc7c5UBJmBn2xrWeVbq79t">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3947486%2F&amp;text=Selective%20TBK1%2FIKKi%20dual%20inhibitors%20with%20anti-cancer%20potency" alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3947486%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947486/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC3947486/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/24150799/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC3947486/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/24150799/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC3947486/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/3947486/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=hhs%20author%20manuscript[filter]" class="navlink">HHS Author Manuscripts</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC3947486
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-nihpa.png" alt="Logo of nihpa" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="https://www.hhs.gov/open/public-access-guiding-principles/index.html" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div><span id="pmcmata">Int J Cancer.</span> Author manuscript; available in PMC 2015 Apr 15.</div><div></div><div class="final-form"><em>Published in final edited form as:</em></div><div class="final-citation"><div class="fm-vol-iss-date"><a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=24150799" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CFree%20Access">Int J Cancer. 2014 Apr 15; 134(8): 1972–1980. </a></div><span class="fm-vol-iss-date">Published online 2013 Oct 21. </span> <span class="doi"><span>doi: </span><a href="//doi.org/10.1002%2Fijc.28507" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1002/ijc.28507</a></span></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC3947486</span></div><div class="fm-citation-manuscriptid"><span class="fm-citation-ids-label">NIHMSID: </span><span>NIHMS531308</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/24150799">24150799</a></div></div></div><h1 class="content-title">Selective TBK1/IKKi dual inhibitors with anti-cancer potency</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Li%20J%5BAuthor%5D" class="affpopup" co-rid="_co_idm140627243068624" co-class="co-affbox">Jijia Li</a>,<sup>1,</sup><sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Huang%20J%5BAuthor%5D" class="affpopup" co-rid="_co_idm140627237068688" co-class="co-affbox">Jingjia Huang</a>,<sup>3</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Jeong%20JH%5BAuthor%5D" class="affpopup" co-rid="_co_idm140627243065616" co-class="co-affbox">Ji-Hak Jeong</a>,<sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Park%20SJ%5BAuthor%5D" class="affpopup" co-rid="_co_idm140627280037520" co-class="co-affbox">Sun-Jin Park</a>,<sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wei%20R%5BAuthor%5D" class="affpopup" co-rid="_co_idm140627280035536" co-class="co-affbox">Rui Wei</a>,<sup>2,</sup><sup>4</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Peng%20J%5BAuthor%5D" class="affpopup" co-rid="_co_idm140627276957328" co-class="co-affbox">Jieying Peng</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Luo%20Z%5BAuthor%5D" class="affpopup" co-rid="_co_idm140627276955344" co-class="co-affbox">Zhiyong Luo</a>,<sup>3</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Chen%20YT%5BAuthor%5D" class="affpopup" co-rid="_co_idm140627237254624" co-class="co-affbox">Yen Ting Chen</a>,<sup>5</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Feng%20Y%5BAuthor%5D" class="affpopup" co-rid="_co_idm140627237252640" co-class="co-affbox">Yangbo Feng</a>,<sup>5,</sup><sup>*</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Luo%20JL%5BAuthor%5D" class="affpopup" co-rid="_co_idm140627232565472" co-class="co-affbox">Jun-Li Luo</a><sup>2,</sup><sup>*</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140627243068624"><h3 class="no_margin">Jijia Li</h3><p><sup>1</sup>Department of Stomatology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China</p><p><sup>2</sup>Department of Cancer Biology, The Scripps Research Institute, Jupiter, FL 33458, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Li%20J%5BAuthor%5D">Jijia Li</a></div></div><div id="_co_idm140627237068688"><h3 class="no_margin">Jingjia Huang</h3><p><sup>3</sup>School of Life Science, Central South University, Changsha, Hunan 410008, China</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Huang%20J%5BAuthor%5D">Jingjia Huang</a></div></div><div id="_co_idm140627243065616"><h3 class="no_margin">Ji-Hak Jeong</h3><p><sup>2</sup>Department of Cancer Biology, The Scripps Research Institute, Jupiter, FL 33458, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Jeong%20JH%5BAuthor%5D">Ji-Hak Jeong</a></div></div><div id="_co_idm140627280037520"><h3 class="no_margin">Sun-Jin Park</h3><p><sup>2</sup>Department of Cancer Biology, The Scripps Research Institute, Jupiter, FL 33458, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Park%20SJ%5BAuthor%5D">Sun-Jin Park</a></div></div><div id="_co_idm140627280035536"><h3 class="no_margin">Rui Wei</h3><p><sup>2</sup>Department of Cancer Biology, The Scripps Research Institute, Jupiter, FL 33458, USA</p><p><sup>4</sup>Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wei%20R%5BAuthor%5D">Rui Wei</a></div></div><div id="_co_idm140627276957328"><h3 class="no_margin">Jieying Peng</h3><p><sup>1</sup>Department of Stomatology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Peng%20J%5BAuthor%5D">Jieying Peng</a></div></div><div id="_co_idm140627276955344"><h3 class="no_margin">Zhiyong Luo</h3><p><sup>3</sup>School of Life Science, Central South University, Changsha, Hunan 410008, China</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Luo%20Z%5BAuthor%5D">Zhiyong Luo</a></div></div><div id="_co_idm140627237254624"><h3 class="no_margin">Yen Ting Chen</h3><p><sup>5</sup>Medicinal Chemistry, Translational Research Institute, The Scripps Research Institute, Jupiter, FL 33458, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Chen%20YT%5BAuthor%5D">Yen Ting Chen</a></div></div><div id="_co_idm140627237252640"><h3 class="no_margin">Yangbo Feng</h3><p><sup>5</sup>Medicinal Chemistry, Translational Research Institute, The Scripps Research Institute, Jupiter, FL 33458, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Feng%20Y%5BAuthor%5D">Yangbo Feng</a></div></div><div id="_co_idm140627232565472"><h3 class="no_margin">Jun-Li Luo</h3><p><sup>2</sup>Department of Cancer Biology, The Scripps Research Institute, Jupiter, FL 33458, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Luo%20JL%5BAuthor%5D">Jun-Li Luo</a></div></div></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm140627242235136_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140627242235136_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm140627242235136_ai" style="display:none"><div class="fm-affl" id="A1"><sup>1</sup>Department of Stomatology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China</div><div class="fm-affl" id="A2"><sup>2</sup>Department of Cancer Biology, The Scripps Research Institute, Jupiter, FL 33458, USA</div><div class="fm-affl" id="A3"><sup>3</sup>School of Life Science, Central South University, Changsha, Hunan 410008, China</div><div class="fm-affl" id="A4"><sup>4</sup>Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China</div><div class="fm-affl" id="A5"><sup>5</sup>Medicinal Chemistry, Translational Research Institute, The Scripps Research Institute, Jupiter, FL 33458, USA</div><div id="FN1"><sup>*</sup>Corresponding Author: Jun-Li Luo, Department of Cancer Biology, The Scripps Research Institute, Jupiter, FL 33458, USA. <a href="mailto:dev@null" data-email="ude.sppircs@oullj" class="oemail">ude.sppircs@oullj</a>. Yangbo Feng, Medicinal Chemistry, Translational Research Institute, #2A1, The Scripps Research Institute, Jupiter, FL 33458, USA. <a href="mailto:dev@null" data-email="ude.sppircs@gnefy" class="oemail">ude.sppircs@gnefy</a></div></div><div class="fm-article-notes half_rhythm"></div><div class="permissions half_rhythm hide" id="idm140627242235136_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">PMC Copyright notice</a> </div></div></div><div id="pmclinksbox" class="links-box whole_rhythm" role="complementary" aria-label="Related or updated information about this article."><div>The publisher's final edited version of this article is available free at <a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=24150799" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CFree%20Access">Int J Cancer</a></div></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><h2 class="nomenu">Associated Data</h2><dl data-count="1" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Supp Fig S1-S3 &#x00026; Table S1-S3.</strong></div><div><a href="/pmc/articles/PMC3947486/bin/NIHMS531308-supplement-Supp_Fig_S1-S3___Table_S1-S3.doc" data-ga-action="click_feat_suppl">NIHMS531308-supplement-Supp_Fig_S1-S3___Table_S1-S3.doc</a><span style="color:gray"> (890K)</span></div><div class="small guid">GUID: 48012809-151D-423C-A371-C9D0A454CF90</div></div></dd></dl></div><div id="abstract-a.i.b.u" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="abstract-a.i.b.utitle">Abstract</h2><!--article-meta--><div><p id="P1" class="p p-first-last">Increasing evidence suggests that the non-canonical IKKs play critical roles in tumor genesis and development, leading to the notion that non-canonical IKKs may be good targets for cancer therapy. Here, we demonstrate that although TBK1 is not over-expressed or constitutively activated in some tumor cells, targeting IKKi induces the activation of TBK1. Therefore, simultaneously targeting both kinases is necessary to efficiently suppress tumor cell proliferation. We show that three TBK1/IKKi dual inhibitors, which are based on a structurally rigid 2-amino-4-(3&#x02032;-cyano-4&#x02032;-pyrrolidine)phenyl-pyrimidine scaffold, potently inhibit cell viability in human breast, prostate, and oral cancer cell lines. Treatment with these TBK1/IKKi dual inhibitors significantly impairs tumor development in xenograft and allograft mouse models. The anti-cancer function of these inhibitors may be due partially to their suppression of TBK1/IKKi-mediated AKT phosphorylation and VEGF expression. Most importantly, these TBK1/IKKi dual inhibitors have drug-like properties including low molecular weight, low Cytochrome P450 inhibition, and high metabolic stability. Therefore, our studies provide proof of concept for further drug discovery efforts that may lead to novel strategies and new therapeutics for the treatment of human cancer.</p></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">TBK1, IKKi, TBK1/IKKi inhibitor, cancer, therapy</span></div></div><div id="S1" class="tsec sec"><h2 class="head no_bottom_margin" id="S1title">Introduction</h2><p id="P2" class="p p-first">The IKK family includes four kinase members, the canonical IKK&#x003b1; and IKK&#x003b2;, as well as two non-canonical family members, TBK1 and IKKi. The canonical IKK complex consists of IKK&#x003b1;, IKK&#x003b2; and a nonenzymatic regulatory component, IKK&#x003b3;/NEMO <sup><a href="#R1" rid="R1" class=" bibr popnode">1</a></sup>. NF-&#x003ba;B is generally activated through canonical IKK-dependent phosphorylation and subsequent degradation of I&#x003ba;B inhibitory proteins <sup><a href="#R2" rid="R2" class=" bibr popnode">2</a></sup>. Liberated NF-&#x003ba;B dimers then enter the nucleus where they induce the transcription of various genes <sup><a href="#R3" rid="R3" class=" bibr popnode">3</a>, <a href="#R4" rid="R4" class=" bibr popnode">4</a></sup>. By contrast, TBK1 and IKKi are especially critical for antiviral responses via phosphorylation and activation of the transcription factors IRF3, IRF7, and STAT1 <sup><a href="#R5" rid="R5" class=" bibr popnode">5</a>, <a href="#R6" rid="R6" class=" bibr popnode">6</a></sup>. Although TBK1 and IKKi are not a part of the canonical IKK complex, they were originally characterized as activators of NF-&#x003ba;B and are believed to target multiple NF-&#x003ba;B members and effectors <sup><a href="#R5" rid="R5" class=" bibr popnode">5</a></sup>. However, NF-&#x003ba;B activation in either TBK1 or IKKi single and double knockout models is predominantly normal, apart from minimal defects in the induction of select NF-&#x003ba;B target genes <sup><a href="#R7" rid="R7" class=" bibr popnode">7</a>, <a href="#R8" rid="R8" class=" bibr popnode">8</a></sup>, indicating that the non-canonical IKKs are sufficient, but not essential for NF-&#x003ba;B activation.</p><p id="P3">In addition to their role in antiviral immune responses, the non-canonical IKKs play important roles in tumor genesis and development <sup><a href="#R9" rid="R9" class=" bibr popnode">9</a>&#x02013;<a href="#R11" rid="R11" class=" bibr popnode">11</a></sup>. It was reported that TBK1 kinase activity was up-regulated and required for the survival of some transformed cells <sup><a href="#R9" rid="R9" class=" bibr popnode">9</a>, <a href="#R12" rid="R12" class=" bibr popnode">12</a></sup>. Silencing TBK1 expression by RNAi induced tumor cell apoptosis, while non-tumorigenic epithelial cells did not depend on TBK1 for survival <sup><a href="#R9" rid="R9" class=" bibr popnode">9</a></sup>. An integrative genomic approach showed IKKi as an oncogene in human breast cancer, and suppression of IKKi expression in breast cancer cell lines with IKKi DNA amplifications induced cell death <sup><a href="#R13" rid="R13" class=" bibr popnode">13</a></sup>. Moreover, a recent report showed that TBK1 and IKKi activated AKT by direct phosphorylation of AKT <sup><a href="#R14" rid="R14" class=" bibr popnode">14</a>,<a href="#R15" rid="R15" class=" bibr popnode">15</a></sup>.</p><p id="P4" class="p p-last">Based on their critical roles in tumor cell survival, the non-canonical IKKs are becoming attractive targets for cancer therapy <sup><a href="#R16" rid="R16" class=" bibr popnode">16</a>&#x02013;<a href="#R19" rid="R19" class=" bibr popnode">19</a></sup>. Here, we demonstrate that both TBK1 and IKKi are essential for tumor cell survival. Simultaneously targeting both kinases is an efficient way to suppress tumor cell proliferation. We identify selective TBK1/IKKi dual inhibitors with high potency of anti-proliferation in human cancer cell lines. Treatment of these TBK1/IKKi dual inhibitors significantly impairs tumor development in xenograft and allograft mouse models.</p></div><div id="S2" class="tsec sec"><h2 class="head no_bottom_margin" id="S2title">Materials and methods</h2><div id="S3" class="sec sec-first"><h3 id="S3title">Cell culture and materials</h3><p id="P5" class="p p-first-last">Human oral cancer cell lines (SCC-9, SCC-15, SCC-25), human prostate cancer cell lines (PC3, DU145, LNCaP), human breast cancer cell lines (MCF-7, MBA-MB-231, T-47D) and RAW264.7 macrophages, purchased from American Type Culture Collection (ATCC), were maintained in respective medium as recommended in protocols. Myc-CaP mouse prostate cancer cell line, which was isolated from a c-Myc transgenic mouse with prostate cancer, and can grow as tumors in immune competent FVB mice in an androgen dependent manner, was kindly provided by Charles Sawyers, MSKCC. Myc-CaP cells were cultured in RPMI-1640 medium supplemented with 10% heat-inactivated FBS, penicillin-streptomycin 100 units/ml. Lipopolysaccharides (LPS, from Escherichia coli 055:B5) were purchased from Sigma-Aldrich Co. (Saint Louis, Missouri).</p></div><div id="S4" class="sec"><h3 id="S4title">TBK1/IKKi dual inhibitors</h3><p id="P6" class="p p-first-last">In counterscreening studies of our in-house 4-phenyl-pyrimidine based JNK inhibitors, we discovered that some JNK inhibitor candidates showed strong TBK1/IKKi inhibition (Patent: Scripps, WO2009032861 and <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure 1</a>). After structure modifications and SAR (structure-activity relationship) studies, we successfully generated some potent TBK1/IKKi dual inhibitors (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplemtary Table 1 and 2</a>). It should be noted that we realized recently that our compounds are structurally similar to those reported in the Dominex patent applications (Domainex, WO2012010826, CAS#1356225-62-1, and CAS#1354224-35-8). For cell culture experiments TBK1/IKKi dual inhibitors were dissolved in DMSO, for animal studies TBK1/IKKi dual inhibitors were dissolved in a mixture of 5%DMSO:10%Tween-80:85%H2O.</p></div><div id="S5" class="sec"><h3 id="S5title">RNA interference</h3><p id="P7" class="p p-first-last">Cells at 50% confluency were transfected with 50 nM scrambled small interfering RNA (siRNA), TBK1 specific siRNA, or IKKi specific siRNA (Santa Cruz Biotechnology, Santa Cruz, CA) using TransIT-TKO (Mirus Bio Corp., Madison, WI) according to the manufacturer&#x02019;s instructions.</p></div><div id="S6" class="sec"><h3 id="S6title">MTT assay</h3><p id="P8" class="p p-first-last">Cell viability was examined by using the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazoliumbromide (MTT) colorimetric assay (Molecular Probe, Life Technologies, INC, Grand Island, NY). Briefly, cells were plated in 96-well plates at a density of 3&#x02013;4 &#x000d7; 10<sup>3</sup> cells per well, cells were treated with indicated inhibitors or vehicles for 72 hr, followed by addition of MTT for at least 4 hr. The absorbance was measured at 570/630 nm using a spectrophotometer (SpectraMax M5; Molecular Devices Crop). Cell viability (%) was calculated as follows: 
(OD<sub>570</sub> - OD<sub>630</sub> of the samples/OD<sub>570</sub> - OD<sub>630</sub> of the control) × 100 (%).</p></div><div id="S7" class="sec"><h3 id="S7title">Apoptosis analysis</h3><p id="P9" class="p p-first-last">Apoptosis was examined by using the TUNEL assay - based ApopTag in situ Apoptosis detection kit (Chemicon, Temecula, CA) according to manufacturer&#x02019;s instructions. Apoptotic cells were counted and compared between different groups.</p></div><div id="S8" class="sec"><h3 id="S8title">Western blot analysis</h3><p id="P10" class="p p-first-last">Cell lysates were separated by SDS-PAGE and transferred to PVDF membranes. Immunostaining was performed using antibodies specific for TBK1/NAK (D1B4) Rabbit mAb, IKKi (D61F9) XP Rabbit mAb, Phospho-TBK1/NAK (Ser172) (D52C2) XP Rabbit mAb, Phospho-IKKi (Ser172) (D1B7) Rabbit mAb, IRF-3 (D83B9) Rabbit mAb, Phospho-IRF-3 (Ser396) (4D4G) Rabbit mAb, Phospho-CYLD (Ser418) Antibody, CYLD (D1A10) Rabbit mAb, Cleaved Caspase-9 (Asp330) (D2D4) Rabbit mAb, Cleaved Caspase-3 (Asp175) (5A1E) Rabbit mAb, Cleaved Caspase-7 (Asp198) (D6H1) Rabbit mAb, Cleaved PARP (Asp214) (D64E10) XP Rabbit mAb, AKT (pan) (40D4) Mouse mAb, Phospho-AKT (Thr308) (244F9) Rabbit mAb, Phospho-AKT (Ser473) (D9E) XP Rabbit mAb purchased from Cell Signaling Technology (Danvers, MA) and Cyclin D1 Antibody (M-20), &#x003b2;-actin purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Immunoreactive proteins were detected by chemoluminescence using the Pierce ECL Western Blotting Substrate (Thermo Scientific, Rockford, IL).</p></div><div id="S9" class="sec"><h3 id="S9title">Reverse Transcription (RT)-PCR assay</h3><p id="P11" class="p p-first-last">Tumor tissue was homogenized with lysis buffer (RNeasy mini kit, QIAGEN Science, Germantown, MD) on ice. Total RNA was purified using RNeasy mini kit. Reverse transcription was carried out using High Capacity cDNA Reverse Transcription Kit (Applied Biosystems by Life Technologies, Foster City, CA). The sequences of the primers were as follows: for VEGF, 5&#x02032;-CTACCTCCACCATGCCAAGT-3&#x02032; (sense) and 5&#x02032;-TCTCTCCTATGTGCTGGCCT-3&#x02032; (antisense); for &#x003b2;-actin, 5&#x02032;-CATCGTCACCAACTGGGAC-3&#x02032; (sense) and 5&#x02032;-CGATTTCCCGCTCGGCCGTGG-3&#x02032; (antisense).</p></div><div id="S10" class="sec"><h3 id="S10title">Mouse tumor models</h3><p id="P12" class="p p-first-last">For SCC-9 xenograft model, eight-weeks old nu/nu mice (Charles River Laboratories) weight at 22&#x02013;24 g were used. For Myc-CaP allograft model, eight-weeks old FVB male mice (Charles River Laboratories) weight at 22&#x02013;24 g were used. The mice were housed with a regular 12 hr light/12 hr dark cycle and were kept in a pathogen-free environment. SCC-9 cells (1&#x000d7;10<sup>7</sup> cells) mixed in Matrigel, were injected into nude mice subcutaneously, Myc-CaP cells (3&#x000d7;10<sup>6</sup> cells) mixed in Matrigel were inoculated into FVB mice subcutaneously. One day after cell implantation, the mice were randomly divided into two groups (For SCC-9 xenograft model, N = 5 for control group and N=12 for treatment group; for Myc-CaP allograft model, N = 6 for control group and treatment group). Mice were administered <em>ip</em> with TBK1/IKKi kinase dual inhibitor 200A (100 mg/kg) or vehicles once a day. Tumor growth in these mice was monitored and measured every 3 days. The tumor volumes were calculated by the equation V (mm<sup>3</sup>) = a &#x000d7; b<sup>2</sup>/2, where &#x0201c;a&#x0201d; is the largest diameter and &#x0201c;b&#x0201d; is the perpendicular diameter.</p></div><div id="S11" class="sec"><h3 id="S11title">Immunohistochemistry</h3><p id="P13" class="p p-first-last">Immunohistochemistry was done on SCC-9 xenograft tumor tissue frozen sections using the VECTASTAIN Elite ABC Kit (Universal) (Vector Laboratories, Burlingame, CA). The primary antibodies were mouse monoclonal VEGF (C-1) antibody (SC-7269, Santa Cruz Biotechnology) at 1:200 dilution, rabbit polyclonal phosphor-AKT (Ser 473) antibody (Cell Signaling Technology, Danvers, MA) at 1:200 dilution.</p></div><div id="S12" class="sec sec-last"><h3 id="S12title">Statistical analysis</h3><p id="P14" class="p p-first-last">All cell MTT data were from at least three independent experiments performed in triplicate and expressed as the mean &#x000b1; SD. A P-value of &#x0003c;0.05 between experimental and control groups were considered statistically significant. ANOVA with general linear model repeated measures were used to determine tumor volume difference among different groups over treatment time, followed by post-hoc Tukey test. The Student&#x02019;s t test was also used for univariate analysis. A value of P &#x0003c; 0.05 were considered significant. Immunostaining was expressed as the arithmetic mean &#x000b1; SD and each evaluated with an unpaired t test. Apoptotic index data were expressed as the mean number &#x000b1; SD in each tumor area, and nonparametric comparisons (&#x003c7;<sup>2</sup>) were made for each treatment group compared with their respective control. A value of P &#x0003c; 0.05 were considered statistically significant</p></div></div><div id="S13" class="tsec sec"><h2 class="head no_bottom_margin" id="S13title">Results</h2><div id="S14" class="sec sec-first"><h3 id="S14title">Both TBK1 and IKKi are essential for tumor cell survival</h3><p id="P15" class="p p-first-last">TBK1 and IKKi have been well established as regulators of the innate immune response via their ability to phosphorylate IFN regulatory transcription factors 3 and 7 (IRF3/IRF7). Recent evidence indicates that TBK1 and IKKi are also involved in promoting cell survival and tumorigenesis. To establish whether TBK1 and IKKi are constitutively activated in cancer cells, we checked the phosphorylation levels of TBK1 and IKKi in a number of cancer cell lines. We found that IKKi was expressed and phosphorylated in all cancer cell lines examined while TBK1 was selectively phosphorylated in certain cancer cell lines (<a href="/pmc/articles/PMC3947486/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1A</span></a>). The expression of p-TBK1 was very low or undetectable by western blot in human oral cancer cell line SCC-25. However, knockdown of IKKi in SCC-25 cells induced both TBK1 and p-TBK1 expression (<a href="/pmc/articles/PMC3947486/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1B</span></a>), suggesting that inhibition of IKKi leads to a compensatory expression and phosphorylation of TBK1. Consistently, although IKKi is constitutively phosphorylated in SCC-25 cells, knockdown of either IKKi or TBK1 respectively had only minor effects on cell survival while knockdown of both TBK1 and IKKi significantly inhibited cell proliferation (<a href="/pmc/articles/PMC3947486/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1C</span></a>). These results suggest that both TBK1 and IKKi are essential for cancer cell survival, inhibiting either one is not enough to inhibit cancer cell proliferation. Thus, simultaneously targeting both TBK1 and IKKi is necessary for efficient suppression of cancer cell growth.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC3947486/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140627278918288"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3947486_nihms531308f1.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms531308f1.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3947486/bin/nihms531308f1.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140627278918288"><a target="object" rel="noopener" href="/pmc/articles/PMC3947486/figure/F1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC3947486/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Both TBK1 and IKKi are essential for cancer cell survival</strong><p>(A) Western blot analysis of the expression of p-IKKi, IKKi, p-TBK1, TBK1 in indicated cell lines.</p><p>(B) Western blot analysis of the expression of IKKi, p-TBK1, TBK1 in oral cancer cell line SCC-25 transfected with scrambled or IKKi-siRNA for 72 hr.</p><p>(C) Cell proliferation analysis of SCC-25 cells transfected with indicated siRNAs. The results are present as the means &#x000b1; SD of one representative experiment (from three independent experiments), performed in triplicate. Statistically significant differences are indicated. (*) <em>P</em> &#x0003c; 0.05; (**) <em>P</em> &#x0003c; 0.01. The knockdown efficiency was verified by western blot.</p></div></div></div></div><div id="S15" class="sec"><h3 id="S15title">Identification of selective TBK1 and IKKi dual inhibitors</h3><p id="P16" class="p p-first">To demonstrate that the dual inhibition of TBK1 and IKKi is an effective and safe way to suppress tumor growth, we generated highly potent TBK1/IKKi dual inhibition compounds which are based on a structurally rigid 2-amino-4-(3&#x02032;-cyano-4&#x02032;-pyrrolidine)phenyl-pyrimidine scaffold. In counterscreening studies of our in-house 4-phenyl-pyrimidine based JNK inhibitors, we discovered that some of the JNK inhibitor candidates showed strong TBK1/IKKi inhibition (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure 1</a>). After structure modifications and structure-activity relationship (SAR) studies, we successfully developed compounds with significant reduction in anti-JNK activity while keeping a strong TBK1/IKKi inhibition (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Table 1 and 2</a>). Compounds SR8185, 200A, and 200B exhibited low nanomolar activities against TBK1 and IKKi in enzyme assays and had good polar surface area (PSA) values as well (<a href="/pmc/articles/PMC3947486/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2A</span></a> and <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Table 1</a>). Counterscreening studies demonstrated that these compounds are selective against ALK, CDK4, CDK5, CK1d, JNK, IKK&#x003b2;, IKK&#x003b1;, ROCK, PKA, p38 (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Table 2</a>). Remarkably, SAR studies demonstrated that there was no need for a heavy halo-substitution (iodo- or bromo-) on the molecule in order to obtain high potency and selectivity, and this heavy halo-substitution is required in several published structures for TBK1/IKKi inhibition <sup><a href="#R17" rid="R17" class=" bibr popnode">17</a>, <a href="#R18" rid="R18" class=" bibr popnode">18</a></sup>. The inhibition profile of a compound against cytochrome P450 enzymes (CYPs) is also an important property to evaluate in drug development. As shown in <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Table 1</a>, inhibitor 200A showed an activity against four selected P450 isoforms with IC<sub>50</sub> values estimated to be &#x0003e; 1000-fold higher than its activity against IKKi/TBK1, which indicates that 200A is a promising lead for further drug discovery efforts. The stability of these inhibitors in human and rat microsomes was also assessed. Among these three inhibitors 200A had the best stability.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC3947486/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140627241734928"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms531308f2.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms531308f2.jpg" src="/pmc/articles/PMC3947486/bin/nihms531308f2.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140627241734928"><a target="object" rel="noopener" href="/pmc/articles/PMC3947486/figure/F2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC3947486/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>The structure and the kinase inhibition of TBK1/IKKi dual inhibitors</strong><p>(A) Structures of selected TBK1/IKKi dual inhibitors - SR8185, 200A and 200B.</p><p>(B) Western blot analysis of IRF3 and p-IRF-3 (Ser396) in RAW264.7 cells treated with different concentrations of indicated TBK1/IKKi dual inhibitors for 1 hr, followed by incubation with LPS (1 &#x003bc;g/ml) for 1 hr.</p></div></div></div><p id="P17" class="p p-last">To investigate the potency of TBK1/IKKi kinase inhibition of these new compounds in living cells, we tested whether LPS-induced activation of IRF3 in macrophages can be blocked by the treatment of these compounds<sup><a href="#R20" rid="R20" class=" bibr popnode">20</a>, <a href="#R21" rid="R21" class=" bibr popnode">21</a></sup>. We verified that LPS treatment induced phosphorylation of IRF3 in RAW264.7 cells as expected (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure 2</a>). RAW264.7 cells were then treated with SR8185, 200A, or 200B at different concentrations for 1hr, followed by LPS treatment for 1 hr, cells then were collected for western blot analysis. We found that treatment with these compounds reduced or completely blocked LPS-induced phosphorylation of IRF-3 (<a href="/pmc/articles/PMC3947486/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2B</span></a>). It was noted that compound 200A displayed the best inhibition. These results suggest that these compounds might exert their cellular activity via inhibiting TBK1/IKKi kinase.</p></div><div id="S16" class="sec"><h3 id="S16title">TBK1/IKKi dual inhibitors suppress cancer cell proliferation <em>in vitro</em></h3><p id="P18" class="p p-first">To test the anti-cancer potency of these TBK1/IKKi kinase dual inhibitors, we treated a group of cancer cell lines including oral cancer cells (SCC-9, SCC-15, SCC-25), prostate cancel cells (PC3, DU145, LNCaP, Myc-CaP), and breast cancer cells (MCF-7, MDA-MB-231, T-47D) with different concentrations of these compounds for 3 days, and the cell viability was determined by MTT assay. We found that these TBK1/IKKi kinase dual inhibitors have a potent anti-proliferative effect on all cancer cell lines examined although the sensitivity of cancer cells to these dual inhibitors are various among different cell lines (<a href="/pmc/articles/PMC3947486/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3</span></a>). These compounds displayed potent cytotoxic activities on cancer cell lines, with IC<sub>50</sub> values in low micromolar range (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Table 3</a>). Among these compounds, 200A presented high anti-proliferative activity in all tested cancer cell lines, with the lowest IC50.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC3947486/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140627239756912"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3947486_nihms531308f3.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms531308f3.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3947486/bin/nihms531308f3.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140627239756912"><a target="object" rel="noopener" href="/pmc/articles/PMC3947486/figure/F3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC3947486/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Figure 3</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>TBK1/IKKi dual inhibitors suppress cancer cell proliferation</strong><p>(A&#x02013;C) Oral cancer cell lines, (D&#x02013;G) prostate cancer cell lines, and (H&#x02013;J) breast cancer cell lines were treated with different concentrations of indicated TBK1/IKKi dual inhibitors for 72 hr, cell proliferation was analyzed by MTT assay. Cell viability (%) was calculated as (OD570&#x02212;OD630 of the samples/OD570&#x02212;OD630 of the control) &#x000d7;100 (%).</p><p>The results are the means &#x000b1; SD of one representative experiment (from three independent experiments), performed in triplicate.</p></div></div></div><p id="P19" class="p p-last">Cyclin D1, whose activity is required for cell cycle G1/S transition, is a well-known marker for cell cycle progression and proliferation. Consistent with the anti-proliferation function, TBK1/IKKi dual inhibitors reduced Cyclin D1 expression in SSC-9 cells in a time-dependent manner (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure 3</a>).</p></div><div id="S17" class="sec"><h3 id="S17title">TBK1/IKKi dual inhibitors induce cancer cell apoptosis <em>in vitro</em></h3><p id="P20" class="p p-first-last">MTT assays showed strong anti-proliferation potency of these TBK1/IKKi kinase dual inhibitors in different cancer cell lines. To further investigate the cytotoxicity of these dual inhibitors, SCC-9 cells were treated with 1.0 &#x003bc;M of TBK1/IKKi kinase dual inhibitor 200A for 72 hr, and then the effect on apoptosis was measured. We found that the treatment of TBK1/IKKi kinase dual inhibitor 200A induced significant apoptosis in SCC-9 cells (<a href="/pmc/articles/PMC3947486/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4A</span></a>). Consistently, the expression of the pro-apoptotic proteins was significantly increased in a time and dose -dependent manner when SCC-9 cells were exposed to TBK1/IKKi kinase dual inhibitor 200A (cleaved caspase-3 and cleaved PARP: P&#x0003c;0.01) (<a href="/pmc/articles/PMC3947486/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4B and 4C</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F4" co-legend-rid="lgnd_F4"><a href="/pmc/articles/PMC3947486/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140627239752976"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3947486_nihms531308f4.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms531308f4.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3947486/bin/nihms531308f4.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140627239752976"><a target="object" rel="noopener" href="/pmc/articles/PMC3947486/figure/F4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F4"><div><a class="figpopup" href="/pmc/articles/PMC3947486/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4">Figure 4</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>TBK1/IKKi dual inhibitors induce apoptosis in cancer cells</strong><p>(A) Apoptotic cells in SCC-9 cells, treated with 1.0 &#x003bc;M 200A for 72 hr, were identified by TUNEL staining (red). Cells were counterstained with DAPI (blue).</p><p>(B) Western blot analysis of apoptotic protein in SCC-9 cells treated with 1.0 &#x003bc;M 200A for different time.</p><p>(C) Western blot analysis of apoptotic protein in SCC-9 cells treated with 200A at different concentrations for 24 hr.</p><p>The results in (B) and (C) are the means &#x000b1; SD of one representative experiment from three independent experiments.</p></div></div></div></div><div id="S18" class="sec"><h3 id="S18title">TBK1/IKKi dual inhibitors suppress tumor growth in mouse models</h3><p id="P21" class="p p-first">Based on the anti-proliferative effect of the TBK1/IKKi dual inhibitors on cancer cells <em>in vitro</em> and other biochemical characteristics, we chose compound 200A to test the anti-tumor growth efficacy of TBK1/IKKi dual inhibitors in mouse models. Nu/nu mice were inoculated subcutaneously (s.c.) in both flanks with 2 &#x000d7; 10<sup>7</sup> SSC-9 cells. One day after cell inoculation, mice were randomly divided into two groups. One group was treated with TBK1/IKKi dual inhibitor 200A (ip, 100mg/Kg, once per day), and another group was treated with vehicles. Tumor growth was monitored and measured every three days. Tumor volumes were calculated by the equation V (mm<sup>3</sup>) = a &#x000d7; b<sup>2</sup>/2, where &#x0201c;a&#x0201d; is the largest diameter and &#x0201c;b&#x0201d; is the perpendicular diameter (<a href="/pmc/articles/PMC3947486/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig. 5A</span></a>). Thirty-four days later, mice were sacrificed and tumors were collected, weighed (<a href="/pmc/articles/PMC3947486/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig. 5B</span></a>), and photographed (<a href="/pmc/articles/PMC3947486/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig. 5C</span></a>). Notably, the treatment of 200A significantly suppressed the growth of SSC-9 xenograft tumor in nude mice.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F5" co-legend-rid="lgnd_F5"><a href="/pmc/articles/PMC3947486/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140627238461296"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3947486_nihms531308f5.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms531308f5.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3947486/bin/nihms531308f5.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140627238461296"><a target="object" rel="noopener" href="/pmc/articles/PMC3947486/figure/F5/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F5"><div><a class="figpopup" href="/pmc/articles/PMC3947486/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5">Figure 5</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>TBK1/IKKi dual inhibitors suppress tumor growth in mouse models</strong><p>(A&#x02013;C) 1&#x000d7;10<sup>7</sup> SCC-9 cells were inoculated into nu/nu mice subcutaneously. One day after cell implantation, mice were randomly divided into two groups. One group was administered <em>ip</em> with TBK1/IKKi kinase dual inhibitor 200A (100 mg/kg, once a day), another group treated with vehicles. Tumor growth was monitored and measured every three days (A). The tumor volumes were calculated by the equation V (mm<sup>3</sup>) = a &#x000d7; b<sup>2</sup>/2, where &#x0201c;a&#x0201d; is the largest diameter and &#x0201c;b&#x0201d; is the perpendicular diameter. Thirty-four days later, mice were sacrificed and tumors were removed, weighed (B), and photographed (C). Note: Xenograft tumors No.11 and 12 regressed after 200A treatment.</p><p>(D&#x02013;F) 3&#x000d7;10<sup>6</sup> Myc-CaP cells were inoculated into FVB mice subcutaneously. One day after cell implantation, mice were randomly divided into two groups. One group was administered <em>ip</em> with TBK1/IKKi kinase dual inhibitor 200A (100 mg/kg, once a day), another group treated with vehicles. Tumor growth was monitored and measured every three days (D). Eighteen days later, mice were sacrificed and tumors were removed, weighed (E), and photographed (F).</p><p>The results in (A), (B), (D), and (E) are the mean &#x000b1; SD (* <em>P</em> &#x0003c; 0.05; ** <em>P</em> &#x0003c; 0.01).</p></div></div></div><p id="P22">In another mouse model, we employed the Myc-CaP mouse prostate cancer cell line. This cell line was isolated from a c-Myc transgenic mouse with prostate cancer, and can grow as tumors in immune competent FVB mice in an androgen dependent manner. 3&#x000d7;10<sup>6</sup> Myc-CaP cells were inoculated s.c. into FVB mice. One day after cell implantation, mice were randomly divided into two groups. One group was administered <em>ip</em> with 200A (100 mg/kg, once a day), and another group treated with vehicles. Tumor growth was monitored and measured every three days (<a href="/pmc/articles/PMC3947486/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig. 5D</span></a>). Eighteen days later, mice were sacrificed and tumors were collected, weighed (<a href="/pmc/articles/PMC3947486/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig. 5E</span></a>), and photographed (<a href="/pmc/articles/PMC3947486/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig. 5F</span></a>). Similar to that seen with the SCC-9 xenograft model described above, the treatment of TBK1/IKKi kinase dual inhibitor 200A significantly slowed down the growth of Myc-CaP allograft tumors in FVB mice.</p><p id="P23" class="p p-last">It should be noted that there were no apparent signs of toxicity in both Nu/Nu and FVB mice treated with 200A, as evidenced by body weight and other life symptom monitoring. Therefore, TBK1/IKKi dual inhibitor 200A showed a safe and potent anti-tumor effect in tumor mouse models. Thus, the data indicate that simultaneous inhibition of both TBK1 and IKKi might be an efficient way to suppress tumor development.</p></div><div id="S19" class="sec sec-last"><h3 id="S19title">TBK1/IKKi dual inhibitors suppress the expressions of p-CYLD and p-AKT, and angiogenesis</h3><p id="P24" class="p p-first">It has been reported that phosphorylation of the tumor suppressor CYLD by IKKi promotes cell transformation <sup><a href="#R22" rid="R22" class=" bibr popnode">22</a></sup>. To examine whether TBK1/IKKi dual inhibitors suppress CYLD phosphorylation, SCC-9 cells were treated with different TBK1/IKKi dual inhibitors for 1 hr, and cells were collected for western blot. We found that SCC-9 cells treated with TBK1/IKKi dual inhibitors had less p-CYLD expression than that in controls (<a href="/pmc/articles/PMC3947486/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Fig. 6A</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F6" co-legend-rid="lgnd_F6"><a href="/pmc/articles/PMC3947486/figure/F6/" target="figure" rid-figpopup="F6" rid-ob="ob-F6"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140627239970608"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms531308f6.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms531308f6.jpg" src="/pmc/articles/PMC3947486/bin/nihms531308f6.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140627239970608"><a target="object" rel="noopener" href="/pmc/articles/PMC3947486/figure/F6/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F6"><div><a class="figpopup" href="/pmc/articles/PMC3947486/figure/F6/" target="figure" rid-figpopup="F6" rid-ob="ob-F6">Figure 6</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Reduced expression of p-CYLD, Cyclin D1, p-AKT, and VEGF in TBK1/IKKi dual inhibitor-treated tumor cells or tissues</strong><p>(A) Western blot analysis of CYLD and p-CYLD (Ser418) in SCC-9 cells cells treated with 1.0 &#x003bc;M of indicated TBK1/IKKi dual inhibitors for 1 hr.</p><p>(B) Western blot analysis of total and phosphorylated AKT (S473, T308) in SCC-9 cells treated with different concentration of 200A for 30 min.</p><p>(C) Western blot analysis of AKT and p-AKT in tumor tissue from mice treated with or without 200A.</p><p>(D) Immunohistochemical staining of p-AKT in tumor tissue from mice treated with or without 200A. Tissues were counterstained with hematoxylin (blue) (Magnification 400 X). The relative p-AKT expression shown in right panel is present as the mean &#x000b1; SD (* p&#x0003c;0.05).</p><p>(E) RT-PCR analysis of VEGF in tumor tissue from mice treated with or without 200A.</p><p>(F) Immunohistochemical staining of VEGF in SCC-9 xenograft tumors from mice treated with or without 200A. Tissues were counterstained with hematoxylin (blue) (Magnification 400 X). The relative VEGF expression shown in right panel is present as the mean &#x000b1; SD (* <em>P</em> &#x0003c; 0.05).</p></div></div></div><p id="P25">AKT plays a pivotal role in fundamental cellular functions such as cell proliferation and survival. Recently it was reported that both TBK1 and IKKi phosphorylate AKT <sup><a href="#R14" rid="R14" class=" bibr popnode">14</a>, <a href="#R15" rid="R15" class=" bibr popnode">15</a>, <a href="#R23" rid="R23" class=" bibr popnode">23</a>, <a href="#R24" rid="R24" class=" bibr popnode">24</a></sup>. To investigate whether TBK1/IKKi dual inhibitors affect AKT phosphorylation, SCC-25 cells were treated with different doses of 200A for 30 min and cells were then collected for western blot. We found that treatment with 200A decreased p-AKT expression in a dose-dependent manner (<a href="/pmc/articles/PMC3947486/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Fig. 6B</span></a>). Similarly, western blot and immunohistochemistry analysis showed that treatment with TBK1/IKKi dual inhibitor 200A led to significant reduction of p-AKT expression in xenograft tumor tissues (<a href="/pmc/articles/PMC3947486/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Fig. 6C and 6D</span></a>). These results suggest that the anti-tumor effect of TBK1/IKKi dual inhibitors may be via their suppression of AKT activation.</p><p id="P26" class="p p-last">It has been reported that AKT1 regulates pathological angiogenesis, vascular maturation and permeability <em>in vivo</em>
<sup><a href="#R25" rid="R25" class=" bibr popnode">25</a></sup>. Since our results showed TBK1/IKKi dual inhibitors reduced AKT activation in both cancer cell lines and tumor tissues, we asked whether TBK1/IKKi dual inhibitors affect VEGF expression and angiogenesis in tumors. We therefore used RT-PCR and immunohistochemistry to examine VEGF expression in tumors from 200A- treated and control mice. We found that tumor tissues from 200A-treated mice had much less VEGF expression compared with untreated groups (<a href="/pmc/articles/PMC3947486/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Fig. 6E and 6F</span></a>). Altogether, these results suggest that the anti-cancer function of TBK1/IKKi dual inhibitors may be mediated by their suppression of AKT activation, leading to impaired angiogenesis and therefore the inhibition of tumor growth.</p></div></div><div id="S20" class="tsec sec"><h2 class="head no_bottom_margin" id="S20title">Discussion</h2><p id="P27" class="p p-first">Accumulating evidence support that the non-canonical IKKs, both TBK1 and IKKi, play critical roles in tumor genesis and development <sup><a href="#R9" rid="R9" class=" bibr popnode">9</a>&#x02013;<a href="#R11" rid="R11" class=" bibr popnode">11</a></sup>, leading to the notion that non-canonical IKKs may be good targets for cancer therapy. In the present study, we have generated potent TBK1/IKKi selective dual inhibitors which are based on a structurally rigid 2-amino-4-(3&#x02032;-cyano-4&#x02032;-pyrrolidine)phenyl-pyrimidine scaffold. Many of these TBK1/IKKi dual inhibitors exhibited high potency of anti-cell proliferation in human breast, prostate, and oral cancer cell lines. Treatment with these TBK1/IKKi dual inhibitors significantly impairs tumor development in xenograft and allograft models. Most importantly, these TBK1/IKKi dual inhibitors have drug-like properties including low molecular weight, low cytochrome P450 (CYPs) inhibition, and high metabolic stability.</p><p id="P28">There are several reasons why we prefer TBK1 and IKKi dual inhibitors rather than single isoform-selective inhibitors for the treatment of cancer: A) Necessity of double TBK1-IKKi inhibition. Consistent with another report <sup><a href="#R6" rid="R6" class=" bibr popnode">6</a></sup>, our results demonstrate that even though TBK1 may not be over-expressed or constitutively activated in some tumor cells, targeting IKKi will induce the activation of TBK1. Therefore, simultaneously targeting both TBK1 and IKKi is necessary to suppress tumor cell proliferation. Therefore, TBK1 and IKKi dual inhibitors represent new opportunities for drug development. B) Safe and effective targets. IKKi knockout mice are viable, fertile and largely normal <sup><a href="#R26" rid="R26" class=" bibr popnode">26</a></sup>. Silencing TBK1 expression by RNAi was found to induce tumor cell apoptosis, while non-tumorigenic epithelial cells do not depend on TBK1 for survival <sup><a href="#R9" rid="R9" class=" bibr popnode">9</a></sup>. Therefore, targeting TBK1 and IKKi might be a safe and effective means of suppressing cancer development that could yield few side effects related to conventional cancer therapy and avoid notorious side effects associated with complete IKK&#x003b2;/NF-&#x003ba;B inhibition. It was reported that although the non-canonical IKKs are not essential for I&#x003ba;B degradation, TBK1/IKKi phosphorylate key targets downstream of the canonical IKK complex (including NF-&#x003ba;B itself), and induce a group of well-characterized NF-&#x003ba;B target genes <sup><a href="#R27" rid="R27" class=" bibr popnode">27</a>, <a href="#R28" rid="R28" class=" bibr popnode">28</a></sup>. However, NF-&#x003ba;B activation in either TBK1 or IKKi single and double knockout models is predominantly normal, apart from minimal defects in the induction of select NF-&#x003ba;B target genes <sup><a href="#R7" rid="R7" class=" bibr popnode">7</a>, <a href="#R8" rid="R8" class=" bibr popnode">8</a></sup>, indicating that the non-canonical IKKs are sufficient, but not essential for NF-&#x003ba;B activation. Our compounds selectively inhibit TBK1 and IKKi without affecting IKK&#x003b2; activity. Thus, application of these compounds will not significantly block NF-&#x003ba;B activation (data not shown), and therefore will avoid the notorious side effects associated with complete IKK&#x003b2;/NF-&#x003ba;B inhibition. It should be noted that the insufficient blockage of NF-&#x003ba;B should not affect the anti-cancer efficacy of TBK1 and IKKi dual inhibition as the contribution of both TBK1 and IKKi to cancer development may not be mainly through transiently activated NF-&#x003ba;B. We recently reported that the cause and maintenance of constitutive NF-&#x003ba;B activation are different from those of its transient activation <sup><a href="#R29" rid="R29" class=" bibr popnode">29</a>, <a href="#R30" rid="R30" class=" bibr popnode">30</a></sup>. It is the constitutively activated (rather than the transiently activated) NF-&#x003ba;B that plays a key role in the maintenance of the malignancy of cancer cells <sup><a href="#R29" rid="R29" class=" bibr popnode">29</a>, <a href="#R30" rid="R30" class=" bibr popnode">30</a></sup>, thus, it will be interesting to examine if TBK1 and IKKi dual inhibition blocks constitutively activated NF-&#x003ba;B in cancer cells while sparing NF-&#x003ba;B transient activation in immune cells.</p><p id="P29">The non-canonical IKKs are well established as regulators of the innate immune response via their abilities to phosphorylate IRF-3/7 transcription factors. However, the role and the mechanism of non-canonical IKKs in mediating inflammatory interferon responses are not related to their function in cancer <sup><a href="#R10" rid="R10" class=" bibr popnode">10</a></sup>. It was reported that IKKi was up-regulated in breast cancer cells by CK-2 <sup><a href="#R31" rid="R31" class=" bibr popnode">31</a></sup>, and that IKKi regulates NF-&#x003ba;B target genes through phosphorylation of p65 at Ser536 <sup><a href="#R32" rid="R32" class=" bibr popnode">32</a></sup>. It was also reported that TBK1 suppressed apoptosis in K-Ras-transformed cells through c-Rel and by up-regulation of Bcl-xL <sup><a href="#R11" rid="R11" class=" bibr popnode">11</a></sup>. Recently, TBK1 and IKKi have been shown to directly phosphorylate AKT <sup><a href="#R14" rid="R14" class=" bibr popnode">14</a>, <a href="#R15" rid="R15" class=" bibr popnode">15</a>, <a href="#R23" rid="R23" class=" bibr popnode">23</a>, <a href="#R24" rid="R24" class=" bibr popnode">24</a></sup>. Consistently, we found that our TBK1/IKKi dual inhibitor significantly suppressed the expression of p-AKT in cancer cells and in tumor tissues, suggesting that the anti-tumor effect of TBK1/IKKi dual inhibitors may be, at least partially, via their suppression of AKT activity.</p><p id="P30">Our results demonstrate that TBK1/IKKi dual inhibitors down-regulate the VEGF expression in tumor tissues, suggesting that activation of non-canonical IKKs may promote oncogenic angiogenesis. It has been proposed that angiogenesis usually get full robustness in tumorigenesis when complex positive feedback loop signaling systems become integrative <sup><a href="#R33" rid="R33" class=" bibr popnode">33</a></sup>. A cancer hypoxic microenvironment generates positive loops inducing formation of the vascular functional shunts <sup><a href="#R33" rid="R33" class=" bibr popnode">33</a></sup>. AKT1, whose function is related to pathological angiogenesis, vascular maturation and permeability <sup><a href="#R25" rid="R25" class=" bibr popnode">25</a></sup>, is located at the upstream angiogenic locus of the integrative robustness. Our results show that TBK1/IKKi dual inhibitors inhibit AKT activation in both cancer cell lines and tumor tissues. Thus, the effect of TBK1/IKKi dual inhibitors on VEGF expression and angiogenesis in tumors may be mediated by their suppression of AKT activity.</p><p id="P31" class="p p-last">Finally, we would like to mention that although the present study is focused on characterizing the anti-cancer function of TBK1/IKKi dual inhibitors, these dual inhibitors may also be suitable to the development of novel therapeutics for other non-cancer diseases, such as glaucoma and rheumatoid arthritis.</p></div><div id="unreferenced-ft" class="tsec sec"><div class="unreferenced">​
                    <div class="boxed-text-box whole_rhythm hide-overflow" id="BX1"><div class="caption"><h3 id="caption-a.l.g.atitle">Novelty and impact</h3></div><p id="P32">Our studies demonstrate anti-tumor effects of TBK1/IKKi dual inhibitors, and provide proof of concept for further drug discovery efforts that may lead to novel strategies and efficient therapeutics for the treatment of human cancer.</p></div></div></div><div id="S22" class="tsec sec"><a id="supplementary-material-sec"></a><h2 class="head no_bottom_margin" id="S22title">Supplementary Material</h2><!--/article/body/sec/--><div class="sec suppmat" id="SD1"><h4>Supp Fig S1-S3 &#x00026; Table S1-S3</h4><div class="sup-box half_rhythm" id="d36e717"><a href="/pmc/articles/PMC3947486/bin/NIHMS531308-supplement-Supp_Fig_S1-S3___Table_S1-S3.doc" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(890K, doc)</sup></div></div></div><div id="S23" class="tsec sec"><h2 class="head no_bottom_margin" id="S23title">Acknowledgments</h2><div class="sec"><p>We thank Dr. Antonio L Amelio (Scripps) for critical review of the manuscript. This work was supported by grants from the United States Department of Defense (W81XWH-09-1-0533), National Institute of Health (1R01CA140956-01, 1R21NS073098-01), and monies from the ThinkPinkKids Foundation to J.L.L., by a postdoctoral trainee fellowship from the Frenchman&#x02019;s Creek Women For Cancer Research to J.H.J., Research Fund for International Young Scientist from China Natural Science Foundation to J.H.J. and S.J.P., and fund from Hunan Provincial Innovation Foundation For Postgraduate (CX2011B066) and a scholarship from China Scholarship Council to J. L.</p></div></div><div id="fn-group-a.k.b" class="tsec sec"><h2 class="head no_bottom_margin" id="fn-group-a.k.btitle">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="FN2"> <p class="p p-first-last">There are no conflicts</p></p></div></div><div id="ref-list-a.k.c" class="tsec sec"><h2 class="head no_bottom_margin" id="ref-list-a.k.ctitle">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="R1">1. <span class="element-citation">Rothwarf DM, Karin M. The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus. <span><span class="ref-journal">Sci STKE. </span>1999;<span class="ref-vol">1999</span>:RE1.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11865184" ref="reftype=pubmed&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci+STKE&amp;title=The+NF-kappa+B+activation+pathway:+a+paradigm+in+information+transfer+from+membrane+to+nucleus&amp;author=DM+Rothwarf&amp;author=M+Karin&amp;volume=1999&amp;publication_year=1999&amp;pages=RE1&amp;pmid=11865184&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R2">2. <span class="element-citation">Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. <span><span class="ref-journal">Annu Rev Immunol. </span>2000;<span class="ref-vol">18</span>:621–63.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10837071" ref="reftype=pubmed&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Immunol&amp;title=Phosphorylation+meets+ubiquitination:+the+control+of+NF-[kappa]B+activity&amp;author=M+Karin&amp;author=Y+Ben-Neriah&amp;volume=18&amp;publication_year=2000&amp;pages=621-63&amp;pmid=10837071&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R3">3. <span class="element-citation">Greten FR, Karin M. NF-kB: Linking Inflammation and Immunity to Cancer Development and Progression. <span><span class="ref-journal">Nature Reviews Immunology. </span>2005;<span class="ref-vol">5</span>:749–59.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16175180" ref="reftype=pubmed&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature+Reviews+Immunology&amp;title=NF-kB:+Linking+Inflammation+and+Immunity+to+Cancer+Development+and+Progression&amp;author=FR+Greten&amp;author=M+Karin&amp;volume=5&amp;publication_year=2005&amp;pages=749-59&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R4">4. <span class="element-citation">Luo JL, Kamata H, Karin M. IKK/NF-kappaB signaling: balancing life and death--a new approach to cancer therapy. <span><span class="ref-journal">J Clin Invest. </span>2005;<span class="ref-vol">115</span>:2625–32.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1236696/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16200195" ref="reftype=pubmed&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Invest&amp;title=IKK/NF-kappaB+signaling:+balancing+life+and+death--a+new+approach+to+cancer+therapy&amp;author=JL+Luo&amp;author=H+Kamata&amp;author=M+Karin&amp;volume=115&amp;publication_year=2005&amp;pages=2625-32&amp;pmid=16200195&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R5">5. <span class="element-citation">Shen RR, Hahn WC. Emerging roles for the non-canonical IKKs in cancer. <span><span class="ref-journal">Oncogene. </span>2011;<span class="ref-vol">30</span>:631–41.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3235643/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21042276" ref="reftype=pubmed&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Emerging+roles+for+the+non-canonical+IKKs+in+cancer&amp;author=RR+Shen&amp;author=WC+Hahn&amp;volume=30&amp;publication_year=2011&amp;pages=631-41&amp;pmid=21042276&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R6">6. <span class="element-citation">Clement JF, Meloche S, Servant MJ. The IKK-related kinases: from innate immunity to oncogenesis. <span><span class="ref-journal">Cell Res. </span>2008;<span class="ref-vol">18</span>:889–99.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19160540" ref="reftype=pubmed&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Res&amp;title=The+IKK-related+kinases:+from+innate+immunity+to+oncogenesis&amp;author=JF+Clement&amp;author=S+Meloche&amp;author=MJ+Servant&amp;volume=18&amp;publication_year=2008&amp;pages=889-99&amp;pmid=19160540&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R7">7. <span class="element-citation">Bonnard M, Mirtsos C, Suzuki S, Graham K, Huang J, Ng M, Itie A, Wakeham A, Shahinian A, Henzel WJ, Elia AJ, Shillinglaw W, et al. Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription. <span><span class="ref-journal">EMBO J. </span>2000;<span class="ref-vol">19</span>:4976–85.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC314216/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10990461" ref="reftype=pubmed&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=EMBO+J&amp;title=Deficiency+of+T2K+leads+to+apoptotic+liver+degeneration+and+impaired+NF-kappaB-dependent+gene+transcription&amp;author=M+Bonnard&amp;author=C+Mirtsos&amp;author=S+Suzuki&amp;author=K+Graham&amp;author=J+Huang&amp;volume=19&amp;publication_year=2000&amp;pages=4976-85&amp;pmid=10990461&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R8">8. <span class="element-citation">Hemmi H, Takeuchi O, Sato S, Yamamoto M, Kaisho T, Sanjo H, Kawai T, Hoshino K, Takeda K, Akira S. The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. <span><span class="ref-journal">J Exp Med. </span>2004;<span class="ref-vol">199</span>:1641–50.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2212809/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15210742" ref="reftype=pubmed&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Exp+Med&amp;title=The+roles+of+two+IkappaB+kinase-related+kinases+in+lipopolysaccharide+and+double+stranded+RNA+signaling+and+viral+infection&amp;author=H+Hemmi&amp;author=O+Takeuchi&amp;author=S+Sato&amp;author=M+Yamamoto&amp;author=T+Kaisho&amp;volume=199&amp;publication_year=2004&amp;pages=1641-50&amp;pmid=15210742&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R9">9. <span class="element-citation">Chien Y, Kim S, Bumeister R, Loo YM, Kwon SW, Johnson CL, Balakireva MG, Romeo Y, Kopelovich L, Gale M, Jr, Yeaman C, Camonis JH, et al. RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival. <span><span class="ref-journal">Cell. </span>2006;<span class="ref-vol">127</span>:157–70.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17018283" ref="reftype=pubmed&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=RalB+GTPase-mediated+activation+of+the+IkappaB+family+kinase+TBK1+couples+innate+immune+signaling+to+tumor+cell+survival&amp;author=Y+Chien&amp;author=S+Kim&amp;author=R+Bumeister&amp;author=YM+Loo&amp;author=SW+Kwon&amp;volume=127&amp;publication_year=2006&amp;pages=157-70&amp;pmid=17018283&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R10">10. <span class="element-citation">Boehm JS, Zhao JJ, Yao J, Kim SY, Firestein R, Dunn IF, Sjostrom SK, Garraway LA, Weremowicz S, Richardson AL, Greulich H, Stewart CJ, et al. Integrative genomic approaches identify IKBKE as a breast cancer oncogene. <span><span class="ref-journal">Cell. </span>2007;<span class="ref-vol">129</span>:1065–79.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17574021" ref="reftype=pubmed&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Integrative+genomic+approaches+identify+IKBKE+as+a+breast+cancer+oncogene&amp;author=JS+Boehm&amp;author=JJ+Zhao&amp;author=J+Yao&amp;author=SY+Kim&amp;author=R+Firestein&amp;volume=129&amp;publication_year=2007&amp;pages=1065-79&amp;pmid=17574021&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R11">11. <span class="element-citation">Barbie DA, Tamayo P, Boehm JS, Kim SY, Moody SE, Dunn IF, Schinzel AC, Sandy P, Meylan E, Scholl C, Frohling S, Chan EM, et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. <span><span class="ref-journal">Nature. </span>2009;<span class="ref-vol">462</span>:108–12.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2783335/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19847166" ref="reftype=pubmed&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Systematic+RNA+interference+reveals+that+oncogenic+KRAS-driven+cancers+require+TBK1&amp;author=DA+Barbie&amp;author=P+Tamayo&amp;author=JS+Boehm&amp;author=SY+Kim&amp;author=SE+Moody&amp;volume=462&amp;publication_year=2009&amp;pages=108-12&amp;pmid=19847166&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R12">12. <span class="element-citation">Bodemann BO, White MA. Ral GTPases and cancer: linchpin support of the tumorigenic platform. <span><span class="ref-journal">Nat Rev Cancer. </span>2008;<span class="ref-vol">8</span>:133–40.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18219307" ref="reftype=pubmed&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Cancer&amp;title=Ral+GTPases+and+cancer:+linchpin+support+of+the+tumorigenic+platform&amp;author=BO+Bodemann&amp;author=MA+White&amp;volume=8&amp;publication_year=2008&amp;pages=133-40&amp;pmid=18219307&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R13">13. <span class="element-citation">Boehm JS, Zhao JJ, Yao J, Kim SY, Firestein R, Dunn IF, Sjostrom SK, Garraway LA, Weremowicz S, Richardson AL, Greulich H, Stewart CJ, et al. Integrative genomic approaches identify IKBKE as a breast cancer oncogene. <span><span class="ref-journal">Cell. </span>2007;<span class="ref-vol">129</span>:1065–79.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17574021" ref="reftype=pubmed&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Integrative+genomic+approaches+identify+IKBKE+as+a+breast+cancer+oncogene&amp;author=JS+Boehm&amp;author=JJ+Zhao&amp;author=J+Yao&amp;author=SY+Kim&amp;author=R+Firestein&amp;volume=129&amp;publication_year=2007&amp;pages=1065-79&amp;pmid=17574021&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R14">14. <span class="element-citation">Xie X, Zhang D, Zhao B, Lu MK, You M, Condorelli G, Wang CY, Guan KL. IkappaB kinase epsilon and TANK-binding kinase 1 activate AKT by direct phosphorylation. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2011;<span class="ref-vol">108</span>:6474–9.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3081021/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21464307" ref="reftype=pubmed&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=IkappaB+kinase+epsilon+and+TANK-binding+kinase+1+activate+AKT+by+direct+phosphorylation&amp;author=X+Xie&amp;author=D+Zhang&amp;author=B+Zhao&amp;author=MK+Lu&amp;author=M+You&amp;volume=108&amp;publication_year=2011&amp;pages=6474-9&amp;pmid=21464307&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R15">15. <span class="element-citation">Ou YH, Torres M, Ram R, Formstecher E, Roland C, Cheng T, Brekken R, Wurz R, Tasker A, Polverino T, Tan SL, White MA. TBK1 directly engages Akt/PKB survival signaling to support oncogenic transformation. <span><span class="ref-journal">Mol Cell. </span>2011;<span class="ref-vol">41</span>:458–70.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3073833/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21329883" ref="reftype=pubmed&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cell&amp;title=TBK1+directly+engages+Akt/PKB+survival+signaling+to+support+oncogenic+transformation&amp;author=YH+Ou&amp;author=M+Torres&amp;author=R+Ram&amp;author=E+Formstecher&amp;author=C+Roland&amp;volume=41&amp;publication_year=2011&amp;pages=458-70&amp;pmid=21329883&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R16">16. <span class="element-citation">Bamborough P, Christopher JA, Cutler GJ, Dickson MC, Mellor GW, Morey JV, Patel CB, Shewchuk LM. 5-(1H-Benzimidazol-1-yl)-3-alkoxy-2-thiophenecarbonitriles as potent, selective, inhibitors of IKK-epsilon kinase. <span><span class="ref-journal">Bioorg Med Chem Lett. </span>2006;<span class="ref-vol">16</span>:6236–40.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16997559" ref="reftype=pubmed&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioorg+Med+Chem+Lett&amp;title=5-(1H-Benzimidazol-1-yl)-3-alkoxy-2-thiophenecarbonitriles+as+potent,+selective,+inhibitors+of+IKK-epsilon+kinase&amp;author=P+Bamborough&amp;author=JA+Christopher&amp;author=GJ+Cutler&amp;author=MC+Dickson&amp;author=GW+Mellor&amp;volume=16&amp;publication_year=2006&amp;pages=6236-40&amp;pmid=16997559&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R17">17. <span class="element-citation">Wang T, Block MA, Cowen S, Davies AM, Devereaux E, Gingipalli L, Johannes J, Larsen NA, Su Q, Tucker JA, Whitston D, Wu J, et al. Discovery of azabenzimidazole derivatives as potent, selective inhibitors of TBK1/IKKepsilon kinases. <span><span class="ref-journal">Bioorg Med Chem Lett. </span>2012;<span class="ref-vol">22</span>:2063–9.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22305584" ref="reftype=pubmed&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioorg+Med+Chem+Lett&amp;title=Discovery+of+azabenzimidazole+derivatives+as+potent,+selective+inhibitors+of+TBK1/IKKepsilon+kinases&amp;author=T+Wang&amp;author=MA+Block&amp;author=S+Cowen&amp;author=AM+Davies&amp;author=E+Devereaux&amp;volume=22&amp;publication_year=2012&amp;pages=2063-9&amp;pmid=22305584&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R18">18. <span class="element-citation">Clark K, Plater L, Peggie M, Cohen P. Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase epsilon: a distinct upstream kinase mediates Ser-172 phosphorylation and activation. <span><span class="ref-journal">J Biol Chem. </span>2009;<span class="ref-vol">284</span>:14136–46.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2682862/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19307177" ref="reftype=pubmed&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Use+of+the+pharmacological+inhibitor+BX795+to+study+the+regulation+and+physiological+roles+of+TBK1+and+IkappaB+kinase+epsilon:+a+distinct+upstream+kinase+mediates+Ser-172+phosphorylation+and+activation&amp;author=K+Clark&amp;author=L+Plater&amp;author=M+Peggie&amp;author=P+Cohen&amp;volume=284&amp;publication_year=2009&amp;pages=14136-46&amp;pmid=19307177&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R19">19. <span class="element-citation">McIver EG, Bryans J, Birchall K, Chugh J, Drake T, Lewis SJ, Osborne J, Smiljanic-Hurley E, Tsang W, Kamal A, Levy A, Newman M, et al. Synthesis and structure-activity relationships of a novel series of pyrimidines as potent inhibitors of TBK1/IKKepsilon kinases. <span><span class="ref-journal">Bioorg Med Chem Lett. </span>2012;<span class="ref-vol">22</span>:7169–73.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23099093" ref="reftype=pubmed&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioorg+Med+Chem+Lett&amp;title=Synthesis+and+structure-activity+relationships+of+a+novel+series+of+pyrimidines+as+potent+inhibitors+of+TBK1/IKKepsilon+kinases&amp;author=EG+McIver&amp;author=J+Bryans&amp;author=K+Birchall&amp;author=J+Chugh&amp;author=T+Drake&amp;volume=22&amp;publication_year=2012&amp;pages=7169-73&amp;pmid=23099093&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R20">20. <span class="element-citation">Solis M, Romieu-Mourez R, Goubau D, Grandvaux N, Mesplede T, Julkunen I, Nardin A, Salcedo M, Hiscott J. Involvement of TBK1 and IKKepsilon in lipopolysaccharide-induced activation of the interferon response in primary human macrophages. <span><span class="ref-journal">Eur J Immunol. </span>2007;<span class="ref-vol">37</span>:528–39.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17236232" ref="reftype=pubmed&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Immunol&amp;title=Involvement+of+TBK1+and+IKKepsilon+in+lipopolysaccharide-induced+activation+of+the+interferon+response+in+primary+human+macrophages&amp;author=M+Solis&amp;author=R+Romieu-Mourez&amp;author=D+Goubau&amp;author=N+Grandvaux&amp;author=T+Mesplede&amp;volume=37&amp;publication_year=2007&amp;pages=528-39&amp;pmid=17236232&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R21">21. <span class="element-citation">Gatot JS, Gioia R, Chau TL, Patrascu F, Warnier M, Close P, Chapelle JP, Muraille E, Brown K, Siebenlist U, Piette J, Dejardin E, et al. Lipopolysaccharide-mediated interferon regulatory factor activation involves TBK1-IKKepsilon-dependent Lys(63)-linked polyubiquitination and phosphorylation of TANK/I-TRAF. <span><span class="ref-journal">J Biol Chem. </span>2007;<span class="ref-vol">282</span>:31131–46.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17823124" ref="reftype=pubmed&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Lipopolysaccharide-mediated+interferon+regulatory+factor+activation+involves+TBK1-IKKepsilon-dependent+Lys(63)-linked+polyubiquitination+and+phosphorylation+of+TANK/I-TRAF&amp;author=JS+Gatot&amp;author=R+Gioia&amp;author=TL+Chau&amp;author=F+Patrascu&amp;author=M+Warnier&amp;volume=282&amp;publication_year=2007&amp;pages=31131-46&amp;pmid=17823124&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R22">22. <span class="element-citation">Hutti JE, Shen RR, Abbott DW, Zhou AY, Sprott KM, Asara JM, Hahn WC, Cantley LC. Phosphorylation of the Tumor Suppressor CYLD by the Breast Cancer Oncogene IKK epsilon Promotes Cell Transformation. <span><span class="ref-journal">Molecular Cell. </span>2009;<span class="ref-vol">34</span>:461–72.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2746958/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19481526" ref="reftype=pubmed&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Molecular+Cell&amp;title=Phosphorylation+of+the+Tumor+Suppressor+CYLD+by+the+Breast+Cancer+Oncogene+IKK+epsilon+Promotes+Cell+Transformation&amp;author=JE+Hutti&amp;author=RR+Shen&amp;author=DW+Abbott&amp;author=AY+Zhou&amp;author=KM+Sprott&amp;volume=34&amp;publication_year=2009&amp;pages=461-72&amp;pmid=19481526&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R23">23. <span class="element-citation">Gulen MF, Bulek K, Xiao H, Yu M, Gao J, Sun L, Beurel E, Kaidanovich-Beilin O, Fox PL, Dicorleto PE, Wang JA, Qin J, et al. Inactivation of the Enzyme GSK3alpha by the Kinase IKKi Promotes AKT-mTOR Signaling Pathway that Mediates Interleukin-1-Induced Th17 Cell Maintenance. <span><span class="ref-journal">Immunity. </span>2012;<span class="ref-vol">37</span>:800–12.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3512562/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23142783" ref="reftype=pubmed&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunity&amp;title=Inactivation+of+the+Enzyme+GSK3alpha+by+the+Kinase+IKKi+Promotes+AKT-mTOR+Signaling+Pathway+that+Mediates+Interleukin-1-Induced+Th17+Cell+Maintenance&amp;author=MF+Gulen&amp;author=K+Bulek&amp;author=H+Xiao&amp;author=M+Yu&amp;author=J+Gao&amp;volume=37&amp;publication_year=2012&amp;pages=800-12&amp;pmid=23142783&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R24">24. <span class="element-citation">Guo JP, Coppola D, Cheng JQ. IKBKE protein activates Akt independent of phosphatidylinositol 3-kinase/PDK1/mTORC2 and the pleckstrin homology domain to sustain malignant transformation. <span><span class="ref-journal">J Biol Chem. </span>2011;<span class="ref-vol">286</span>:37389–98.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3199486/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21908616" ref="reftype=pubmed&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=IKBKE+protein+activates+Akt+independent+of+phosphatidylinositol+3-kinase/PDK1/mTORC2+and+the+pleckstrin+homology+domain+to+sustain+malignant+transformation&amp;author=JP+Guo&amp;author=D+Coppola&amp;author=JQ+Cheng&amp;volume=286&amp;publication_year=2011&amp;pages=37389-98&amp;pmid=21908616&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span><link class="retraction-forward" pmcaccid="PMC5077228" /> <a class="red" href="/pmc/articles/PMC5077228/">Retracted</a></span></div><div class="ref-cit-blk half_rhythm" id="R25">25. <span class="element-citation">Chen J, Somanath PR, Razorenova O, Chen WS, Hay N, Bornstein P, Byzova TV. Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo. <span><span class="ref-journal">Nat Med. </span>2005;<span class="ref-vol">11</span>:1188–96.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2277080/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16227992" ref="reftype=pubmed&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;title=Akt1+regulates+pathological+angiogenesis,+vascular+maturation+and+permeability+in+vivo&amp;author=J+Chen&amp;author=PR+Somanath&amp;author=O+Razorenova&amp;author=WS+Chen&amp;author=N+Hay&amp;volume=11&amp;publication_year=2005&amp;pages=1188-96&amp;pmid=16227992&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R26">26. <span class="element-citation">Tenoever BR, Ng SL, Chua MA, McWhirter SM, Garcia-Sastre A, Maniatis T. Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity. <span><span class="ref-journal">Science. </span>2007;<span class="ref-vol">315</span>:1274–8.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17332413" ref="reftype=pubmed&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Multiple+functions+of+the+IKK-related+kinase+IKKepsilon+in+interferon-mediated+antiviral+immunity&amp;author=BR+Tenoever&amp;author=SL+Ng&amp;author=MA+Chua&amp;author=SM+McWhirter&amp;author=A+Garcia-Sastre&amp;volume=315&amp;publication_year=2007&amp;pages=1274-8&amp;pmid=17332413&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R27">27. <span class="element-citation">Fujita F, Taniguchi Y, Kato T, Narita Y, Furuya A, Ogawa T, Sakurai H, Joh T, Itoh M, Delhase M, Karin M, Nakanishi M. Identification of NAP1, a regulatory subunit of IkappaB kinase-related kinases that potentiates NF-kappaB signaling. <span><span class="ref-journal">Mol Cell Biol. </span>2003;<span class="ref-vol">23</span>:7780–93.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC207563/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/14560022" ref="reftype=pubmed&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cell+Biol&amp;title=Identification+of+NAP1,+a+regulatory+subunit+of+IkappaB+kinase-related+kinases+that+potentiates+NF-kappaB+signaling&amp;author=F+Fujita&amp;author=Y+Taniguchi&amp;author=T+Kato&amp;author=Y+Narita&amp;author=A+Furuya&amp;volume=23&amp;publication_year=2003&amp;pages=7780-93&amp;pmid=14560022&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R28">28. <span class="element-citation">Buss H, Dorrie A, Schmitz ML, Hoffmann E, Resch K, Kracht M. Constitutive and interleukin-1-inducible phosphorylation of p65 NF-{kappa}B at serine 536 is mediated by multiple protein kinases including I{kappa}B kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription. <span><span class="ref-journal">J Biol Chem. </span>2004;<span class="ref-vol">279</span>:55633–43.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15489227" ref="reftype=pubmed&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Constitutive+and+interleukin-1-inducible+phosphorylation+of+p65+NF-{kappa}B+at+serine+536+is+mediated+by+multiple+protein+kinases+including+I{kappa}B+kinase+(IKK)-{alpha},+IKK{beta},+IKK{epsilon},+TRAF+family+member-associated+(TANK)-binding+kinase+1+(TBK1),+and+an+unknown+kinase+and+couples+p65+to+TATA-binding+protein-associated+factor+II31-mediated+interleukin-8+transcription&amp;author=H+Buss&amp;author=A+Dorrie&amp;author=ML+Schmitz&amp;author=E+Hoffmann&amp;author=K+Resch&amp;volume=279&amp;publication_year=2004&amp;pages=55633-43&amp;pmid=15489227&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R29">29. <span class="element-citation">Rokavec M, Wu W, Luo JL. IL6-Mediated Suppression of miR-200c Directs Constitutive Activation of Inflammatory Signaling Circuit Driving Transformation and Tumorigenesis. <span><span class="ref-journal">Mol Cell. </span>2012</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3319241/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22364742" ref="reftype=pubmed&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cell&amp;title=IL6-Mediated+Suppression+of+miR-200c+Directs+Constitutive+Activation+of+Inflammatory+Signaling+Circuit+Driving+Transformation+and+Tumorigenesis&amp;author=M+Rokavec&amp;author=W+Wu&amp;author=JL+Luo&amp;publication_year=2012&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R30">30. <span class="element-citation">Rokavec M, Luo JL. The transient and constitutive inflammatory signaling in tumorigenesis. <span><span class="ref-journal">Cell Cycle. </span>2012;<span class="ref-vol">11</span>:2587–8.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3409001/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22751429" ref="reftype=pubmed&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Cycle&amp;title=The+transient+and+constitutive+inflammatory+signaling+in+tumorigenesis&amp;author=M+Rokavec&amp;author=JL+Luo&amp;volume=11&amp;publication_year=2012&amp;pages=2587-8&amp;pmid=22751429&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R31">31. <span class="element-citation">Eddy SF, Guo S, Demicco EG, Romieu-Mourez R, Landesman-Bollag E, Seldin DC, Sonenshein GE. Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cells. <span><span class="ref-journal">Cancer Res. </span>2005;<span class="ref-vol">65</span>:11375–83.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16357145" ref="reftype=pubmed&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Inducible+IkappaB+kinase/IkappaB+kinase+epsilon+expression+is+induced+by+CK2+and+promotes+aberrant+nuclear+factor-kappaB+activation+in+breast+cancer+cells&amp;author=SF+Eddy&amp;author=S+Guo&amp;author=EG+Demicco&amp;author=R+Romieu-Mourez&amp;author=E+Landesman-Bollag&amp;volume=65&amp;publication_year=2005&amp;pages=11375-83&amp;pmid=16357145&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R32">32. <span class="element-citation">Adli M, Baldwin AS. IKK-i/IKKepsilon controls constitutive, cancer cell-associated NF-kappaB activity via regulation of Ser-536 p65/RelA phosphorylation. <span><span class="ref-journal">J Biol Chem. </span>2006;<span class="ref-vol">281</span>:26976–84.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16840782" ref="reftype=pubmed&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=IKK-i/IKKepsilon+controls+constitutive,+cancer+cell-associated+NF-kappaB+activity+via+regulation+of+Ser-536+p65/RelA+phosphorylation&amp;author=M+Adli&amp;author=AS+Baldwin&amp;volume=281&amp;publication_year=2006&amp;pages=26976-84&amp;pmid=16840782&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R33">33. <span class="element-citation">Radisavljevic Z. AKT as locus of cancer angiogenic robustness and fragility. <span><span class="ref-journal">J Cell Physiol. </span>2013;<span class="ref-vol">228</span>:21–4.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22585603" ref="reftype=pubmed&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Cell+Physiol&amp;title=AKT+as+locus+of+cancer+angiogenic+robustness+and+fragility&amp;author=Z+Radisavljevic&amp;volume=228&amp;publication_year=2013&amp;pages=21-4&amp;pmid=22585603&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3947486&amp;issue-id=234798&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC3947486/pdf/nihms531308.pdf" class="int-view">PDF (3.6M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/3947486/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/3947486/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="3947486" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3947486%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="ObJOhcBXJkyTQ3k0EdgSU1xrQ9l2FDrGR8kfwdAB8vcc7c5UBJmBn2xrWeVbq79t">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3947486%2F&amp;text=Selective%20TBK1%2FIKKi%20dual%20inhibitors%20with%20anti-cancer%20potency" alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3947486%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947486/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC3947486/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/24150799/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC3947486/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/24150799/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC3947486/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/3947486/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript" src="/core/mathjax/2.7.9/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC3947486/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
